Breaking News Instant updates and real-time market news.

CYNA

Cynapsus Therapeutics

$40.46

0.02 (0.05%)

09:12
10/18/16
10/18
09:12
10/18/16
09:12

Cynapsus Therapeutics obtains final court order, HSR waiting period expiration

Cynapsus Therapeutics announced that it has obtained a final order from the Ontario Superior Court of Justice approving the previously announced plan of arrangement with Sunovion Pharmaceuticals Inc. In addition, the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended, has expired with respect to the Arrangement. Receipt of the Final Order and the expiration of the HSR waiting period satisfy two of the conditions to the closing of the Arrangement, which remains subject to other customary closing conditions. Cynapsus expects that the Arrangement will be completed on or about October 21.

CYNA Cynapsus Therapeutics
$40.46

0.02 (0.05%)

07/19/16
JANY
07/19/16
NO CHANGE
Target $24
JANY
Buy
Cynapsus Phase 3 DTP results bode well for study, says Janney Capital
Janney Capital analyst Ken Trbovich believes the open-label dose titration phase, or DTP, results reported by Cynapsus Therapeutics support his expectation that the Phase 3 trial will likely result in a clinically and statistically significant difference from placebo during the randomized portion of the study. The analyst keeps a Buy rating and $24 fair value estimate on Cynapsus shares.
07/20/16
BMOC
07/20/16
NO CHANGE
BMOC
Cynapsus Therapeutics price target raised to $25 from $21 at BMO Capital
BMO Capital increased its price target on Cynapsus citing its belief that the company's APL drug will be approved in Europe. The firm keeps an Outperform rating on the shares.
08/16/16
BMOC
08/16/16
NO CHANGE
BMOC
Cynapsus Therapeutics price target raised to $30 from $25 at BMO Capital
BMO Capital analyst Do Kim raised his price target on Cynapsus after the Data and Safety Monitoring Board, or DSMB, said that patients participating in a trial of the company's APL at-home titration product could use it at home. The analyst thinks that at-home titration appeals to doctors, and he says that the DSMB's recommendation highlights the superior safety and tolerability of the product versus injectable Apokyn. The analyst keeps an Outperform rating on Cynapsus.
09/01/16
JANY
09/01/16
DOWNGRADE
Target $40.5
JANY
Neutral
Cynapsus Therapeutics downgraded to Neutral from Buy at Janney Capital
Janney Capital analyst Ken Trbovich downgraded Cynapsus Therapeutics to Neutral citing the company's takeover by Sunovion Pharmaceuticals. The analyst has a $40.50 price target for the shares.

TODAY'S FREE FLY STORIES

09:45
02/28/17
02/28
09:45
02/28/17
09:45
General news
U.S. equities are flatlining ahead of Trump's SOTU speech »

U.S. equities are…

09:45
02/28/17
02/28
09:45
02/28/17
09:45
General news
Consumer Confidence to be reported at 10:00 »

February Consumer…

HPP

Hudson Pacific

09:43
02/28/17
02/28
09:43
02/28/17
09:43
Downgrade
Hudson Pacific rating change  »

Hudson Pacific downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Feb

CMCSA

Comcast

$37.53

-0.36 (-0.95%)

, CMCSK

Comcast

09:41
02/28/17
02/28
09:41
02/28/17
09:41
Hot Stocks
Comcast NBCUniversal to acquire remaining 49% stake in Universal Studios Japan »

Comcast NBCUniversal…

CMCSA

Comcast

$37.53

-0.36 (-0.95%)

CMCSK

Comcast

GS

Goldman Sachs

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Mar

  • 03

    Mar

  • 06

    Mar

AMTD

TD Ameritrade

$43.66

0.25 (0.58%)

, P

Pandora

09:41
02/28/17
02/28
09:41
02/28/17
09:41
Options
Unusually active option classes on open February 28th »

Unusual total active…

AMTD

TD Ameritrade

$43.66

0.25 (0.58%)

P

Pandora

HTZ

Hertz

NEM

Newmont Mining

VRX

Valeant

WMT

Wal-Mart

X

U.S. Steel

T

AT&T

CRM

Salesforce

GLD

SPDR Gold Trust

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Feb

  • 28

    Feb

  • 28

    Feb

  • 28

    Feb

  • 28

    Feb

  • 28

    Feb

  • 28

    Feb

  • 02

    Mar

  • 06

    Mar

  • 06

    Mar

  • 14

    Mar

  • 14

    Mar

  • 14

    Mar

  • 19

    Mar

SIG

Signet Jewelers

09:39
02/28/17
02/28
09:39
02/28/17
09:39
Technical Analysis
Signet Jewelers drops to new 52-week low in early trading »

The stock is down over…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Mar

MTU

Mitsubishi UFJ

09:38
02/28/17
02/28
09:38
02/28/17
09:38
Upgrade
Mitsubishi UFJ rating change  »

Mitsubishi UFJ upgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CZR

Caesars

$9.45

0.3 (3.28%)

, LVS

Las Vegas Sands

09:38
02/28/17
02/28
09:38
02/28/17
09:38
Hot Stocks
Nevada reports January Statewide gaming win up 12.02% to $1.04B »

Reports December Las…

CZR

Caesars

$9.45

0.3 (3.28%)

LVS

Las Vegas Sands

WYNN

Wynn Resorts

$95.51

1.5 (1.60%)

PENN

Penn National

$14.47

0.25 (1.76%)

MGM

MGM Resorts

BYD

Boyd Gaming

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Feb

DF

Dean Foods

09:36
02/28/17
02/28
09:36
02/28/17
09:36
Upgrade
Dean Foods rating change  »

Dean Foods upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TGT

Target

09:34
02/28/17
02/28
09:34
02/28/17
09:34
Hot Stocks
Target sees 2%-4% sales lift from reimagined stores »

Says to open 30 new small…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Feb

  • 19

    Mar

JPM

JPMorgan

09:33
02/28/17
02/28
09:33
02/28/17
09:33
Hot Stocks
Breaking Hot Stocks news story on JPMorgan »

JPMorgan says…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Feb

  • 28

    Feb

  • 03

    Mar

  • 14

    Jul

  • 12

    Oct

  • 13

    Apr

  • 13

    Jul

  • 12

    Oct

09:33
02/28/17
02/28
09:33
02/28/17
09:33
General news
Market opens with modest losses »

Stock futures drifted…

JBT

JBT Corporation

09:32
02/28/17
02/28
09:32
02/28/17
09:32
Upgrade
JBT Corporation rating change  »

JBT Corporation upgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Feb

BCOV

Brightcove

$8.20

0.05 (0.61%)

, HUBS

HubSpot

09:31
02/28/17
02/28
09:31
02/28/17
09:31
Hot Stocks
Brightcove, HubSpot announce partnership »

Brightcove (BCOV) and…

BCOV

Brightcove

$8.20

0.05 (0.61%)

HUBS

HubSpot

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Mar

  • 02

    Mar

  • 13

    Mar

  • 14

    Mar

ESND

Essendant

$22.09

0.34 (1.56%)

09:31
02/28/17
02/28
09:31
02/28/17
09:31
Downgrade
Essendant rating change  »

Essendant downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Feb

HYH

Halyard Health

09:30
02/28/17
02/28
09:30
02/28/17
09:30
Downgrade
Halyard Health rating change  »

Halyard Health downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

09:30
02/28/17
02/28
09:30
02/28/17
09:30
General news
The U.S. advance indicators report »

The U.S. advance…

09:30
02/28/17
02/28
09:30
02/28/17
09:30
General news
Chicago PMI Business Barometer Index to be reported at 09:45 »

February Chicago PMI…

PFE

Pfizer

09:29
02/28/17
02/28
09:29
02/28/17
09:29
Hot Stocks
FDA sends Pfizer's Hospira warning letter over manufacturing »

The FDA sent…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Mar

  • 09

    Mar

  • 17

    Mar

  • 23

    Mar

  • 01

    Apr

  • 27

    Aug

FRO

Frontline

09:28
02/28/17
02/28
09:28
02/28/17
09:28
Hot Stocks
Breaking Hot Stocks news story on Frontline »

Frontline raises…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Mar

VZ

Verizon

, BPL

Buckeye Partners

09:28
02/28/17
02/28
09:28
02/28/17
09:28
Conference/Events
Morgan Stanley to hold a conference »

MLP/Diversified Natural…

VZ

Verizon

BPL

Buckeye Partners

CEQP

Crestwood Equity

ENLC

EnLink Midstream

ENLK

EnLink Midstream Partners

EPD

Enterprise Products

SEMG

SemGroup

VLP

Valero Energy Partners

OGS

ONE Gas

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Feb

  • 28

    Feb

  • 28

    Feb

  • 02

    Mar

  • 06

    Mar

SCHW

Charles Schwab

09:27
02/28/17
02/28
09:27
02/28/17
09:27
Hot Stocks
Charles Schwab lowers standard online equity and ETF trade commissions »

The Charles Schwab…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FRO

Frontline

09:25
02/28/17
02/28
09:25
02/28/17
09:25
Earnings
Frontline reports Q4 adj. EPS 22c, consensus 12c »

Reports Q4 revenue $128M,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Mar

EFX

Equifax

09:25
02/28/17
02/28
09:25
02/28/17
09:25
Conference/Events
Equifax to hold a webcast »

Equifax Senior Vice…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Feb

  • 28

    Feb

  • 28

    Feb

  • 01

    Mar

  • 01

    Mar

  • 02

    Mar

  • 02

    Mar

LGND

Ligand

$107.38

7 (6.97%)

09:25
02/28/17
02/28
09:25
02/28/17
09:25
Conference/Events
Ligand to host analyst day »

Analyst Day to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Feb

  • 02

    Mar

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.